Terra Innovatum Global NV Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
Analyst Coverage
5analysts covering
FY EPS (est.)
-$0.20next fiscal year
Monitoring Framework
Key Performance Indicators
Cash and Cash Equivalents Quarterly102.9MTarget: Sufficient to fund FOAK licensing and construction
SOLO Reactor Unit Commercial Pipeline (Non-binding MOUs) Quarterly100Target: Convert to committed orders
Planned Annual Production Capacity of SOLO Units AnnuallyTarget: 400 units per year by 2028
Watch Items
- U.S. Nuclear Regulatory Commission (NRC) Safety Analysis Report SubmissionTrigger: Submission delay past mid-2026Action: Re-evaluate the 2028 commercialization timeline and adjust project milestones.
- Nasdaq Listing Rule 5250(c)(1) ComplianceTrigger: Failure to file Q1 2026 Form 10-Q promptly after the 10-K filingAction: Monitor SEC filings and Nasdaq compliance status to mitigate delisting risks.
- Conversion of Non-binding MOUs to Committed OrdersTrigger: Zero conversion of the 100-unit pipeline over the next 12-18 monthsAction: Review commercial strategy, pricing models, and customer engagement in key sectors like data centers.
Research as of 19 Jun 2026